the cellular pharmacology of doxorubicin resistance ( doxr ) has most commonly been associated with decreased drug uptake , enhanced drug efflux , cross-resistance to multiple anticancer agents , and the overproduction of a mr 170,000 cell surface glycoprotein ( termed p-glycoprotein ) .
C0376622
doxorubicin resistance
C1512072
drug efflux